Abstract
Background: Severe acute respiratory syndrome coronavirus 2 infection is associated with hypercoagulability, which predisposes to venous thromboembolism (VTE). We analyzed platelet and neutrophil activation in patients with coronavirus disease 2019 (COVID-19) and their association with VTE.
Methods: Hospitalized patients with COVID-19 and age- and sex-matched healthy controls were studied. Platelet and leukocyte activation, neutrophil extracellular traps (NETs), and matrix metalloproteinase 9, a neutrophil-released enzyme, were measured. Four patients were restudied after recovery. The activating effect of plasma from patients with COVID-19 on control platelets and leukocytes and the inhibiting activity of common antithrombotic agents on it were studied.
Results: A total of 36 patients with COVID-19 and 31 healthy controls were studied; VTE developed in 8 of 36 patients with COVID-19 (22.2%). Platelets and neutrophils were activated in patients with COVID-19. NET, but not platelet activation, biomarkers correlated with disease severity and were associated with thrombosis. Plasmatic matrix metalloproteinase 9 was significantly increased in patients with COVID-19. Platelet and neutrophil activation markers, but less so NETs, normalized after recovery. In vitro, plasma from patients with COVID-19 triggered platelet and neutrophil activation and NET formation, the latter blocked by therapeutic-dose low-molecular-weight heparin, but not by aspirin or dypiridamole.
Conclusions: Platelet and neutrophil activation are key features of patients with COVID-19. NET biomarkers may help to predict clinical worsening and VTE and may guide low-molecular-weight heparin treatment.
Keywords: SARS-CoV-2; low-molecular weight heparin; matrix metalloproteinase-9 (MMP-9); neutrophil extracellular traps (NETs); venous thromboembolism (VTE).
【저자키워드】 SARS-CoV-2, low-molecular weight heparin, matrix metalloproteinase-9 (MMP-9), neutrophil extracellular traps (NETs), venous thromboembolism (VTE), 【초록키워드】 COVID-19, Treatment, coronavirus disease, Neutrophils, Coronavirus disease 2019, platelet activation, coronavirus, Biomarker, Biomarkers, thrombosis, Neutrophil extracellular traps, disease severity, neutrophil, Infection, Platelets, hospitalized patients, heparin, Venous Thromboembolism, Severe acute respiratory syndrome, Patient, Platelet, Neutrophil extracellular trap, plasma, age, Aspirin, respiratory, predict, NETs, hypercoagulability, association, leukocytes, Antithrombotic, VTE, neutrophil activation, leukocyte, matrix metalloproteinase, acute respiratory syndrome, leukocyte activation, enzyme, healthy control, worsening, help, NET, feature, significantly increased, analyzed, blocked, activated, less, correlated, triggered, inhibiting, activating, were measured, normalized, patients with COVID-19, 【제목키워드】 Complication,